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ABSTRACT
Restriction endonucleases (REases) with 8-base
specificity are rare specimens in nature. NotI from
Nocardia otitidis-caviarum (recognition sequence
50-GCGGCCGC-30) has been cloned, thus allowing
for mutagenesis and screening for enzymes with
altered 8-base recognition and cleavage activity.
Variants possessing altered specificity have been
isolated by the application of two genetic methods.
In step 1, variant E156K was isolated by its ability to
induce DNA-damage in an indicator strain expres-
sing M.EagI (to protect 50-NCGGCCGN-30 sites). In
step 2, the E156K allele was mutagenized with the
objective of increasing enzyme activity towards the
alternative substrate site: 50-GCTGCCGC-30. In this
procedure, clones of interest were selected by their
ability to eliminate a conditionally toxic substrate
vector and induce the SOS response. Thus, specific
DNA cleavage was linked to cell survival. The
secondary substitutions M91V, F157C and V348M
were each found to have a positive effect on specific
activitywhenpaired withE156K.Forexample,variant
M91V/E156K cleaves 50-GCTGCCGC-30 with a speci-
fic activity of 8.2 · 10
4 U/mg, a 32-fold increase
over variant E156K. A comprehensive analysis indic-
ates that the cleavage specificity of M91V/E156K
is relaxed to a small set of 8 bp substrates while
retaining activity towards the NotI sequence.
INTRODUCTION
Considerable progress has been made in isolating restriction
endonucleases (REases) with altered substrate speciﬁcity.
Many of the efforts have employed a DNA-damage indicator
strain as pioneered by Heitman and Model (1,2) who
developed an SOS induction assay to screen for relaxed
variants of EcoRI in order to identify amino acids that make
speciﬁc contacts to cognate DNA. More recently, a genetic
selection and screening procedure lead to the discovery of two
important side chains for BstYI speciﬁcity (wt speciﬁcity is
50-RGATCY-30 where R ¼ Ao rG ,Y¼ C or T). The BstYI
evolution procedure yielded a variant with a marked increase
in substrate speciﬁcity (3). The variant K133N/S172N
possessed a 12-fold preference for AGATCT over AGATCC
or GGATCT and cleavage of GGATCC was no longer detect-
able. In subsequent X-ray structural studies of wt BstYI, only
two amino acid residues were found making base-speciﬁc
contacts to the 50-AGATCT-30 sequence (4). Remarkably,
the two residues were K133 and S172. In a structure-guided
study of BsoBI (speciﬁcity ¼ 50-CYCGRG-30), variant
D246A was found to display a preference for cleavage of
50-CCCGGG-30 (5). Allele D246A was then subjected to
random mutagenesis and in vivo screening to isolate ﬁve
unique variants with increased activity. This study of BsoBI
is the ﬁrst example where a DNA-damage indicator strain was
used for the primary purpose of increasing REase speciﬁc
activity.
A novel approach was applied to Eco57I (50-CTGAAG-30)
to obtain a Type IIG enzyme with altered speciﬁcity (6,7). A
cleavage minus variant was randomly mutated and subjected
to the methylase selection procedure. Challenging the mutant
library in vitro with GsuI (50-CTGGAG-30) enabled isola-
tion of an Eco57I variant with methylation speciﬁcity for
50-CTGRAG-30 and corresponding endonuclease activity
upon restoration of the catalytic residue by site-directed
mutagenesis.
Otherprogresshasbeen madewith altering thespeciﬁcityof
the homing endonuclease I-CreI (8). After determining the
structure of I-CreI bound to its native pseudo-palindromic
22 bp site, several base-contacting positions were chosen for
randomization (9–11). Using a series of two genetic assays
(12), I-CreI variants were analyzed for their ability to cleave
mutant DNA target sites. This in vivo test for cleavage activity
reliably predicted a speciﬁcity shift in several cases and the
*To whom correspondence should be addressed. Tel: +1 978 380 7288; Fax: +1 978 380 7419; Email: samuelson@neb.com
  The Author 2006. Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access
version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press
areattributedastheoriginalplaceofpublicationwiththecorrectcitationdetailsgiven;ifanarticleissubsequentlyreproducedordisseminatednotinitsentiretybut
only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
796–805 Nucleic Acids Research, 2006, Vol. 34, No. 3
doi:10.1093/nar/gkj483approach should allow rapid identiﬁcation of novel endonuc-
leases potentially useful asgene-speciﬁc reagents.The homing
endonuclease PI-SceI was also studied to achieve altered
target site recognition (13). Protein variants were assessed
in vivo using a bacterial two-hybrid system where cell growth
was linked to the ability of protein variants to bind to wt or
mutant target sequences and turn on expression of the HIS3
and aadA genes. These in vivo homing endonuclease studies
were possible due to the infrequency or absence of recognition
sites within Escherichia coli. This feature allowed Gruen et al.
(14) to design a genetic selection system where homing
endonuclease cleavage is linked to cell survival. The authors
proposedthatthissystemmay beusedtoisolate endonucleases
with altered speciﬁcity. The proof of principle study was
carried out with I-SceI, which recognizes an 18 bp sequence.
Upon cell transformation, active endonuclease eliminated a
conditionally toxic substrate vector carrying either two or
four copies of the I-SceI recognition sequence without caus-
ing genomic DNA degradation. Conditional-toxicity was
accomplished by activating the toxic gene product (Barnase
Gln2amb/Asp44amb) by introducing a suppressor tRNA
(supE) at the same time as the endonuclease gene. Recently,
Chen and Zhao (15) reported a cell survival selection method
forevolutionofhomingendonucleasesusingasubstratevector
carrying the ccdB gene under control of the araBAD promoter
and Chames et al. (16) reported a method for homing endo-
nuclease selection in yeast based on the restoration of an
auxotrophic marker via double-strand break induced homo-
logous recombination.
The systems developed for selection of homing endonuc-
leases inspired us to test the feasibility of using in vivo
methods to alter the speciﬁcity of a rare-cutting REase. We
chose to study NotI from Nocardia otitidis-caviarum (ATCC
14630) with the recognition sequence 50-GCGGCCGC-30.
This sequence is present only twenty-three times in the
E.coli K12 genome (17). Despite the low frequency, the
NotI recognition sequence must be modiﬁed to prevent
cell death even when using tightly controlled expression sys-
tems. So initial genetic procedures to alter NotI substrate spe-
ciﬁcity were carried out with methylation of the cognate
recognition sequence, in this case provided by M.EagI (50-
NCGGCCGN-30).
NotI is widely used in molecular biology applications, yet
the protein itself has not been studied in detail. Early work
reported puriﬁcation of NotI from the native strain, and a gel
ﬁltration analysis estimated the molecular mass at 85000 Da
(18). When the notIR gene was cloned by R. Morgan (NEB),
the sequence revealed a calculated molecular weight of
42419 Da for the gene product. Therefore, the primary
form of this Type IIP enzyme is a dimer in the absence of
DNA substrate. Type IIP enzymes are so classiﬁed according
to their homodimeric recognition of palindromic DNA
sequences (19). The eventual objective of this project is to
isolate a NotI variant capable of recognizing and cleaving an
alternative 8-base palindromic sequence. Two parts of this
project will be described. Part 1 consisted of a genetic screen
for variants with altered speciﬁcity and this work yielded
variant E156K. In the second part, variant E156K was further
mutagenized and improved variants were isolated using a
selection/screening system where cell survival is linked to
elimination of a conditionally toxic substrate vector.
MATERIALS AND METHODS
Construction of selection vector ptoxBAC832
A conditionally toxic substrate vector was designed to possess
ten 50-GCTGCCGC-30 cleavage sites (Figure 3). The vector
carries a modiﬁed E.coli yidC gene and the product acts
as a bacteriostat when overproduced by Isopropyl-b-D-
thiogalactopyranoside (IPTG) induction of gene expression
and vector copy number. In earlier studies, overproduction
of 6His-YidC from pPROEX-HTb (Invitrogen) was found
to arrest the growth of E.coli in exponential phase (20). Like-
wise, cells carrying pPROEX-6hisyidC do not form colonies
when plated on LB-agar containing >50 mM IPTG. The wt
yidC gene was transferred to vector pR976 (P. Riggs, NEB)
using the cloning sites NcoI and EcoRI. A DNA linker was
ligated into the NcoI site of pR976-yidC to provide multiple
50-GCTGCCGC-30 substrate sites and to provide coding
sequence for additional N-terminal amino acids, notably
histidine residues. The insertion clones were tested for
conditional-toxicity in strain ER1992 by streaking on LB-
agar containing IPTG. Clone p15A-TC1E imposed lethality
at 1 mM IPTG and was subsequently sequenced to ﬁnd
2 linkers and thus four 50-GCTGCCGC-30 substrate sites at
the beginning of the yidC gene. The coding strand linker
sequence is 50-P-CATGGCTGCCGCGTACTACCACCAC-
CACCTCGATTACGATATCCCAACGACCGAAAACCTG-
TATTTTGCTGCCGC-30. The antisense strand linker
sequence is 50P-CATGGCGGCAGCAAAATACAGGTTTT-
CGGTCGTTGGGATATCGTAATCGAGGTGGTGGTGGT-
AGTACGCGGCAGC-30 (substrate sites are underlined).
Insertion of 2 linkers results in the following extension to
the N-terminus of YidC: NH2-MAAAYYHHHLDYDIPTTE-
NLYFAAAMAAAYYHHHLDYDIPTTENLYFAAA-. The
lacI-yidC gene pair was ampliﬁed from p15A-TC1E by
KOD HiFi DNA polymerase (Novagen) using forward and
reverse primers both containing one 50-GCTGCCGC-30 sub-
strate site. The lacI primer anneals to the lacI promoter
sequence and creates the lacI
q mutation (C!T). The lacI
q
primer sequence is 50-GTGACTGAATTCGCTGCCGCCAC-
CATCGAATGGTGCAAAACCTTTCGCG-30. The yidC
reverse primer sequence is 50-GAGCTCGAATTCGAAGC-
TGCCGCTTCCAATTGGTGTGGCGGATGC-30. The toxic
operon (lacI
q-Ptac-yidC) was cloned into vector pBAClac832,
whose copy number is controlled by LacI repression/IPTG
induction. Vector pBAClac832 was created by combining
seqments of pFOS1 (NEB) and a modiﬁed pUC18. Vector
pUC18 was ﬁrst modiﬁed by replacing the ori RNAII promoter
with the lacZ operator/promoter sequence. Next, the BspHI
site at position 2534 was destroyed, which enabled reversal of
the ampicillin resistance gene (bla) by digestion at BspHI sites
1526 and 2639. Reversal of the bla gene eliminates read-
through transcription from priming plasmid replication.
After bla reversal, IPTG-dependent replication of this
pUC18 derivative was conﬁrmed in strain ER2502 (LacI
+).
Further modiﬁcation to pUC18 consisted of ligating two sub-
strate linkers into the PciI site to insert four 50-GCTGCCGC-30
sites. The modiﬁed pUC origin and bla gene were excised by
SfoI–SalI digestion and ligated into the HpaI site and the
SalI site (at position 2560) of pFOS1 to create pBAClac832.
The toxic operon (lacI
q-Ptac-yidC) was EcoRI-digested and
cloned into the EcoRI sites of pBAClac832 to create the ﬁnal
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tion (without IPTG) was veriﬁed by comparing DNA yields of
ptoxBAC832 to a low-copy reference plasmid after co-
propagation in Luria–Bertani (LB) media containing 0.2%
glucose. The addition of 0.2% glucose is reported to limit
the copy number of BAC clones to one copy (21). The selec-
tion strain was derived from ER1992 (22), a DNA-damage
indicator strain. In addition to carrying the toxic selection
vector, the selection strain also carried a plasmid expressing
M.EagI (23) to protect the NotI and EagI sites within the
E.coli chromosome. ER1992 was ﬁrst transformed with
pSYX20-eagIM (Tet
R) followed by transformation with
ptoxFOS832 to yield the ﬁnal selection strain. The selection
strain was propagated in LB (0.2% glucose) plus 15 mg/ml
tetracycline and 50 mg/ml carbenicillin (Cb). Note that the
selection strain does not grow at higher levels of carbenicillin
or ampicillin as a result of the bla promoter modiﬁcation
(BspHI site mutagenesis). Electro-competent cells ER1992
[pSYX20-eagIM, ptoxBAC832] were prepared by washing
two times with ice-cold 10% glycerol after growth to
OD600 ¼ 0.8. After growth to OD600 ¼ 0.8, toxic vector
maintenance was analyzed by diluting the cell culture and
plating on LB, LB + IPTG, LB + Cb and LB + Cb + IPTG.
Under conditions used in the selection (LB + IPTG), loss of
toxicity was found to occur at a frequency of 0.7% primarily
due to loss of the entire vector. When plated on
LB + Cb + IPTG, loss of toxicity occurs at a frequency of
1 · 10
 4. This indicates that mutation/deletion of tox-yidC
is rare since toxicity is maintained when the bla gene is
maintained.
Transformation of the selection strain
After electroporation, SOC media containing 0.2% glucose
and 0.1 M MgCl2 and 0.1 M MgSO4 was added for cell
recovery and the culture was incubated for 2 h at 37 Ct o
allow for library expression and possible elimination of the
single copy ptoxBAC832. After the 2 h incubation, each
transformation mix was plated on 6 LB-agar plates
(150 · 15 mm) containing 15 mg/ml Tet, 30 mg/ml Cam,
1 mM IPTG and 80 mg/ml X-gal. The presence of 1 mM
IPTG in the agar serves to induce high-copy toxic vector
replication from the pUC origin and, at the same time, the
tox-yidC gene product is over-expressed from Ptac. There-
fore, cells retaining the selection vector after the 2 h incuba-
tion period are prevented from growing on the selection
plates. Increased blue color development is a report of
increased DNA cleavage of substrates differing within the
middle six base pairs of the NotI recognition sequence
(i.e. 50-GCTGCCGC-30).
Bacterial strains
All strains were from the NEB collection. ER2744 [fhuA2
glnV44 e14
  rfbD1? relA1? spoT1? endA1 thi-1 D(mcrC-
mrr)114::IS10 lacZ::T7gene1]. ER2848 [ER2744 with lacI
q
on F0 (Tet
R)]. ER2169 {E.coli B D(mcrC-mrr)102::Tn10 gal
ompT [lon] [dcm]lDE3 ¼ lambda sBamH1o DEcoRI-B
int::lacI::PlacUV5::T7 gene1 i21 D nin5}. ER1992 [endA1
thi-1 glnV44 mcr-67 D(mcrC-mrr)114::IS10 D(argF-
lac)U169 dinD1::MudI1734 (Kan
R, LacZ
+)].
Oligonucleotides for cloning of NotI
The forward degenerate primer used to isolate a fragment of
the NotI gene: 50-GAGCCSGAGGGSGCSAAGTTCAT-30
anneals at codons 8 through 14. The reverse degenerate pri-
mer 50-GASGCGAACTTGTASGCCAT-30 anneals at codons
248 through 242. The forward NotI cloning primer is:
50-GACGCATATGCGTTCCGATACGTCGGTGGAGCCA-
GAG-30. The second and third codons of the gene were
changed to the preferred E.coli codons (underlined). The
reverse cloning primer is: 50-GAATGTCGACCATCTC-
CACCCACG-30.
Plasmid substrates
Substrate pXba was created by ligating an XbaI fragment
of Adenovirus-2 (nt 10579 to 30455) into the XbaI site of
pUC19 (R. Morgan, NEB). The complete sequence of pXba is
available via NEBcutter (http://tools.neb.com/NEBcutter2/
index.php). All single site substrates were created by ligating
annealed oligo duplexes into pUC19 digested with SalI and
BamHI. For example, the pUC-GCT polylinker insert is: 50-
P-TCGACTCTAGAGCTGCCGCTG-30 (top strand).
Mutagenesis
Random mutations were created by notIR gene ampliﬁcation
with Taq DNA polymerase using 25 cycles: (30 s at 94 C, 45 s
at 58 C, 1:45 min at 72 C). Each reaction contained 7 mM
MgSO4 and an unequal ratio of dNTPs (0.2 mM dATP and
dGTP, 1.0 mM dCTP and dTTP). The T7 promoter primer
(NEB S1248S) was used as the forward primer and the reverse
primer was #279-125 (50-CACGATCTCGAGGGCCGGTCC-
GACACCAGG-30). Site-directed mutagenesis was used to
create allele E156K. The forward primer was #286-184
(50-CGATAGCTCGCCGAAGTTTTCATTCGA-30) and the
reverse primer was #286-185 (50-TCGAATGAAAACTTCG-
GCGAGCTATCG-30).
Protein purification
The IMPACT-CN puriﬁcation system (NEB) was used to
express and purify wt NotI and the variants of interest.
Each notIR gene was cloned into the NdeI–SapI sites
of pTYB1. As a result, each REase was expressed as a C-
terminal fusion to the Sce intein and chitin binding domains.
The host for over-expression was E.coli strain ER2848 (24)
carrying pACYC-eagIM and pSYX20-bbvIM. The cells were
grown at 30 Ct oO D 600 ¼ 0.65 and then induced overnight at
30 C with 0.4 mM IPTG. Cell extract was prepared using
chitin column buffer: Tris–HCl (pH 7.8), 500 mM NaCl,
0.1 mM EDTA, 5% glycerol and 0.1% Triton X-100. After
loading and washing, the chitin resin was ﬂushed with column
buffer containing 40 mM DTT. After overnight incubation at
4 C, REase was eluted with chitin column buffer containing
200 mM NaCl. The sodium chloride concentration was then
reduced to 50 mM for DEAE column loading. REase was
eluted from the DEAE column using a 0.05–0.8 M NaCl gra-
dient. Fraction purity was assessed by SDS–PAGE and
REase concentration was determined by the Bradford assay.
Puriﬁed REase was dialyzed into NotI storage buffer [200 mM
NaCl, 20 mM Tris–HCl (pH 7.4), 0.1 mM EDTA, 1 mM DTT
and 50% glycerol] and stored at  20 C.
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Cloning and characterization of wt NotI
The NotI endonuclease gene was cloned by ﬁrst isolating a
fragment of the gene by degenerate primer PCR. The NotI
endonuclease was puriﬁed from N.otitidis-caviarum in order
to perform protein sequencing (25). The protein was digested
with cyanogen bromide, which produced four major peptide
fragments of  24, 10, 4 and 3 kDa in size. Unambiguous
amino acid sequence was determined for the 24, 10 and
4 kDa fragments. The N-terminal sequence of the 24 kDa
peptide was found to match the N-terminal sequence of the
endonuclease (GenBank accession no. DQ242471). Degener-
ate DNA primers based on the amino acid sequence of the
N-terminal region and the 10 kDa fragment were synthesized
and used to amplify this portion of the endonuclease gene
from N.otitidis-caviarum genomic DNA by PCR. The primer
sequences are listed in Materials and Methods. The ampliﬁed
DNA fragment of  680 bp was cloned into pUC19 and
sequenced. The amino acid sequence deduced from the DNA
sequence of this PCR fragment matched the amino acid
sequence of the NotI endonuclease determined by protein
sequencing, conﬁrming that this DNA fragment represented
a portion of the NotI endonuclease gene. A BamHI library of
N.otitidis-caviarum DNA was constructed in a Lambda Dash
vector system to generate clones containing 9 to 23 kb inserts.
The 680 bp fragment of the endonuclease gene was used as a
probe to identify Lambda Dash clones containing this portion
of the endonuclease gene. These lambda clones were puriﬁed
and all were found to contain a common 14.5 kb fragment. The
DNA ﬂanking the probe was sequenced to identify the entire
NotI endonuclease gene. DNA primers were designed to amp-
lify the entire NotI endonuclease gene with an NdeI site at the
50end and a SalI site  500 bp downstream of the 30 end. The
ampliﬁed DNA was ligated into the T7 expression vector
pSYX22 and transformed into E.coli ER2169 competent
cells pre-modiﬁed by M.EagI expressed from pACYC184.
Clones expressing NotI activity were sequenced to conﬁrm
the presence ofawt NotIendonuclease gene. NotIwaspuriﬁed
in order to determine the speciﬁc activity of the enzyme on a
pUC19-derived single site substrate (data not shown). When
using NEB buffer 3, the speciﬁc activity of NotI is 5 · 10
5 U
per mg protein. (One unit is deﬁned as the amount of enzyme
required to linearize 1 mg of pUC-NotI in 1 h at 37 Ci na
reaction volume of 50 ml).
Selection of a NotI variant with
altered cleavage specificity
An SOS induction assay (1,2,22,26,27) was employed to isol-
ate a variant of NotI with altered cleavage speciﬁcity. The
DNA-damage indicator strain ER1992 (22) was transformed
with pACYC184-eagIM (Cam
R) to pre-modify and protect all
50-CGGCCG-30 sites within the genome. Therefore, limited
endonuclease cleavage at sites other than 50-NCGGCCGN-30
were expected toinducetheSOSresponse andresultinexpres-
sion of a dinD1::lacZ gene fusion. A randomly mutated notIR
gene library was ligated into pAGR3 (3) immediately down-
stream of the tac promoter to allow low-level constitutive
expression of the library. After electroporation into ER1992
[pACYC184-eagIM], transformants were selected on LB-agar
plates containing chloramphenicol, ampicillin and X-gal. Of
approximately 60 000 transformants, 10 blue colonies were
isolated. The notIR gene of each clone was ampliﬁed by
colony PCR and each was subcloned into the T7 expression
vector pAII17 (28) for analysis of variant endonuclease activ-
ity. Expression of the NotI variants was conducted in ER2744
[pACYC184-eagIM]. Cell extracts were incubated with the
GC-rich substrate pXba (22562 bp) in order to maximize
the likelihood of observing cleavage of one or more 8 bp
sites related to the NotI recognition sequence. Cell extract
from clone 44-2A produced a cleavage pattern similar to
that shown in lane 7 of Figure 1. Sequencing clone 44-2A
revealed the amino acid substitutions P9S and E156K.
Site-directed mutagenesis was used to create the E156K allele
and cleavage activity of this single variant was indistinguish-
able from the originally selected clone 44-2A (data not
shown). NotI cleaves pXba six times leaving a large fragment
of 16749 bp. By inspection of the pXba sequence, it appeared
thatvariant E156K wascleavingat50-GCTGCCGC-30 inaddi-
tion to the NotI site. Digestion of pBR322 (linearized with
AﬂIII) with cell extract also indicated cleavage at 50-TCGG-
CCGC-30 (Figure 4, lane 5).
Variant E156K was puriﬁed using the IMPACT-CN system
(as described in Materials and Methods). Overproduction in
E.coli was accomplished by providing genomic modiﬁcation
with the C5 methylases M.EagI and M.BbvI [see REBASE
(29), http://rebase.neb.com]. M.BbvI methylates the ﬁrst
cytosine in the 50-GCWGC-30 sequence and this allowed
for greater E156K production as compared to M.EagI modi-
ﬁcation alone (data not shown). Figure 1 displays the results
of incubating puriﬁed E156K with substrate pXba. Lane 7
corresponds to an enzyme to plasmid ratio of 2 (enzyme as
amount of dimer). Near complete digestion of pXba is
observed in lane 9 where the enzyme excess is 16-fold. The
substrate pXba contains nine 50-GCTGCCGC-30 sites and one
50-TCGGCCGC-30 site. A virtual digest of pXba at these sites
plus the NotI sites gave a pattern similar but not identical to
that in lane 9 of Figure 1. To conﬁrm cleavage at 50-GCTGC-
CGC-30 a pUC19-derived substrate containing a single site
Figure 1. Altered cleavage characteristics of NotI variant E156K determined
by digestion of plasmid substrate pXba. Lane 1, no enzyme addition ( );
Lane 2, digestion with 100 U wt NotI; Lanes 3–9, increasing amounts of
variantE156K.LaneM,1kbDNAladder(NEB).Allreactionswereincubated
at 37 C for 60 min in 1· NEB buffer 3.
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tion was achieved with an 8-fold excess of enzyme/substrate
(Figure 2). The expected cut site was veriﬁed by run-off
sequencing of the pUC-GCT linear product (data not
shown). Variant E156K was also incubated with a subst-
rate containing the closely related symmetric sequence 50-
GCTGCAGC-30 but cleavage at this site could not be detected.
Considering these results, the next objective was to increase
the speciﬁc activity of this variant by selecting clones with
secondary mutations.
Selection of variants with enhanced cleavage of
50-GCTGCCGC-30
The second stage of this project was designed to increase the
activity of variant E156K. A novel modiﬁcation to the SOS
induction assay was designed to link cell survival to cleavage
at 50-GCTGCCGC-30. This modiﬁcation was inspired by the
work of Gruen et al. (14). In our selection/screening proced-
ure, strain ER1992 carried the conditionally toxic substrate
vector ptoxBAC832 (Figure 3). IPTG induction of tox-yidC
expression and vector copy number halts cell growth, thus
colony formation is linked to elimination of the toxic vector.
The frequency of colony formation without introduction of
a variant endonuclease library was found to be 0.7% (see
Materials and Methods). The selection strain reports enhanced
cleavage of any non-protected substrate sites (as blue colony
color) but by design only after cleavage of 50-GCTGCCGC-30
results in toxic vector elimination. The selection strain was
modiﬁed by M.EagI, so all 8 bp sites conforming to 50-
NCGGCCGN-30 were protected from endonucleolytic
cleavage. Therefore, blue color development is a report of
increased cleavage of substrates differing within the middle
6 bp of the NotI recognition sequence (i.e. 50-GCTGCCGC-
30). Although blue color development may reﬂect a general
relaxation of substrate speciﬁcity, the in vivo screen places a
strict constraint on the degree of relaxation allowed. As
enzyme speciﬁcity is relaxed, the cell becomes increasingly
susceptible to lethal levels of DNA-damage. Therefore,
NotI variants selected by this in vivo procedure were expected
to fall within a narrow range with regard to substrate speci-
ﬁcity and speciﬁc activity.
A randomly mutated gene library (derived from the E156K
allele) was cloned into three versions of pACYC-T7ter (30) to
determine which vector would provide the appropriate level of
expression for the selection procedure. The appropriate level
of E156K expression would inﬂict a minor level of DNA-
damage on the selection strain so that the dinD1::lacZ reporter
gene would be minimally expressed. In such a scenario,
‘up-mutants’ can be selected. The appropriate expression
vector was determined by comparing the parent vector
pACYC-T7ter with two other versions where deletions
were made upstream of the T7 promoter. Vector pACYC-
T7DSP was modiﬁed by a SmaI–PshAI deletion, which
removes the lacI gene and the four rrnb transcriptional
terminators upstream of the T7 promoter. Vector pACYC-
T7terDEP was modiﬁed by an EcoNI–PshAI deletion,
which removes only the lacI gene. The net effect of each
deletion is increased expression of the notI library gene
from read-through transcription of the chloramphenicol res-
istance gene (cat). Since the selection strain ER1992 does not
express the T7 RNA polymerase, cat read-through transcripts
serve as the primary source of notIR mRNA from pACYC-
T7terDEP and pACYC-T7DSP. Vector pACYC-T7terDEP
was chosen as the library vector according to the phenotype
presented by the parent clone encoding E156K.The phenotype
of E156K was light-blue when transformed into the selection
strain.
The mutated library was prepared from the notIR E156K
allele by error-prone PCR mutagenesis and the product was
cloned into pACYC-T7terDEP. Approximately 10 ng of liga-
tion mix was transformed into the selection strain in each of
two electroporation reactions. The normal plating efﬁciency
Figure 2. Variant E156K digestion of a substrate containing a single
50-GCTGCCGC-30 site. Plasmid pUC-GCT was derived from pUC19. The
enzyme/substrate (E/S) molar ratio is given above each lane. Lane M, 1 kb
DNA ladder. All reactions were incubated at 37 C for 60 min in 1· NEB
BamHI buffer.
Figure 3. An illustration of the conditionally toxic selection vector ptox-
BAC832 prepared by the MapDraw program of DNASTAR Lasergene.
GCT denotes the sequence 50-GCTGCCGC-30. GCA denotes the sequence
50-GCAGCCGC-30. GCC denotes the sequence 50-GCCGCCGC-30. GCGT
denotes the sequence 50-GCGTCCGC-30.
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7 c.f.u./
mg. Under selection conditions (with IPTG), each transforma-
tion yielded  1000 colonies (a 100-fold reduction). A total of
12 medium to dark blue colonies were obtained and the
plasmid DNA from each single colony was isolated by the
QIAprep procedure. The notIR insert of each isolate was
ampliﬁed by PCR using a T7 forward primer (NEB
S1248S) and reverse primer 279-125. Each PCR fragment
was sequenced to determine the NotI variant amino acid
sequence.
Table 1 summarizes the NotI clones isolated from the
ptoxBAC832-mediated selection. The parent clone (variant
E156K) was selected twice. This is a result of processing
all blue survivors regardless of color intensity since the
visual distinction between light or medium blue is not
clear. The other ten selected clones each contained one muta-
tion resulting in an additional amino acid substitution. Most
striking is the repeated selection of double mutants E156K/
F157C and M91V/E156K.
All mutant alleles were cloned into expression vector
pLT7K (31) to enable analysis of activity using cell extracts.
The expression strain ER2848 (24) co-expressed M.EagI and
M.BbvI (50-GCWGC-30) to protect NotI sites and the desired
alternative sites within the host genome. The most active vari-
ants were EP1 (E156K/V348M), EP5-EP8 (E156K/F157C)
and EP10-EP11 (M91V/E156K) as revealed by l DNA diges-
tion (data not shown). Note that l DNA does not encode
any NotI sites but does possess ﬁve 50-GCTGCCGC sites.
The digestion patterns of the three most active double variants
were nearly indistinguishable and similar to the pattern
observed for puriﬁed E156K. Thus, all second site mutations
appeared to primarily enhance speciﬁc activity. Cell extracts
from EP1, EP5 and EP10 were analyzed in more detail by
assessing cleavage of pBR322 (Figure 4). In this assay, variant
EP10 (lane 4) appeared to possess the highest activity (assum-
ing an equal expression level). The expression level of each
variantisgovernedbywhetherhostDNA-damageisprevented
by co-expression of a site-speciﬁc MTase. Therefore, a REase
variant possessing a desired range of speciﬁcity is allowed to
accumulate within the modiﬁed host cells while variants
with undesirable substrate speciﬁcity are lethal or poorly
expressed. This fact is relevant when screening cell extracts
for REase activity. If considerable cleavage activity is
observed, then one may assume that the substrate speciﬁcity
falls primarily within the desired range.
The cleavage speciﬁcity of M91V/E156K was determined
by overdigesting (E/S > 100) the XbaI fragment from nt
10579 to 30455 of Adenovirus-2 DNA. This digestion and
all subsequent reactions were carried out at 37 C in NEB
BamHI buffer [150 mM NaCl, 10 mM Tris–HCl, 10 mM
MgCl2, 1 mM DTT (pH 7.9 at 25 C)]. After digestion, the
cohesive ends were made blunt by T4 DNA polymerase. The
DNA was puriﬁed by QIAprep spin column and ligated to
pUC19 (linearized with HincII and dephosphorylated by
CIP). The ligation mix was transformed into E.cloni 
electro-competent cells (Lucigen). Forty clones containing
insert were isolated by blue/white screening and the ligation
junctions were sequenced with M13/pUC primers S1224S and
S1233S (NEB). By this procedure, DNA cleavage was
conﬁrmed at the sites listed in Table 2 (excluding 50-
GAGGCCGC-30 due to the absence of this site in the substrate
and excluding 50-GGGGCCGC-30). The junction sequences
also veriﬁed that double-strand (ds) cleavage is occurring at
the expected positions to leave 4-base 50 overhangs. The spe-
ciﬁc activity data in Table 2 is summarized from reactions
Table 1. NotI clones isolated from the ptoxBAC832-mediated selection
procedure
Clone name Amino acid substitutions
EP1 E156K/V348M
EP2 E156K only
EP3 E156K/T352A
EP4 E156K/E74V
EP5 E156K/F157C
EP6 E156K/F157C
EP7 E156K/F157C
EP8 E156K/F157C
EP9 E156K only
EP10 M91V/E156K
EP11 M91V/E156K
EP12 E156K/A243V
Figure 4. Evaluation of double variants by digestion of pBR322 (linearized by
AflIII). Lane M, 1 kb DNA ladder; Lane 1, incubation with 100 U wt NotI
to confirm no cleavage of pBR322; Lane 2, incubation with cell extract from
clone EP1 (E156K/ V348M); Lane 3, incubation with cell extract from clone
EP5 (E156K/ F157C); Lane 4, incubation with cell extract from clone EP10
(M91V/ E156K); Lane 5, incubation with cell extract containing variant
E156K. All reactions were at 37 C for 60 min in 1· NEB buffer 3. Production
of 2.9 and 1.5 kb fragments is consistent with cleavage at 50-TCGGCCGC-30.
Table 2. Summary of alternative cleavage sites and specific activity of variant
M91V/E156K
Site
name
Sequence Specific
activity
a
Comments
Notl GCGGCCGC 2.1 · 10
4
AEagC ACGGCCGC 1.6 · 10
5
CEagC CCGGCCGC 1.6 · 10
5
TEagC TCGGCCGC 2.1 · 10
4 Impaired by overlapping Dam
GCA GCAGCCGC – Slow cleavage with E/S >1
GCC GCCGCCGC – Slight cleavage with E/S >1
GCT GCTGCCGC 8.2 · 10
4
GCGA GCGACCGC 1.0 · 10
4
GCGC GCGCCCGC – Slow cleavage with E/S >1
GCGT GCGTCCGC 2.1 · 10
4 Units refer to nicking activity
GAGG GAGGCCGC 8.2 · 10
4
GTGG GTGGCCGC 1.0 · 10
4
GGGG GGGGCCGC – Slow nicking with E/S >1
ATGG ATGGCCGC – Slight cleavage with E/S >1
aSpecific activity is given as units per mg enzyme.
Specific activity was determined by linearizing single site substrates derived
frompUC19.Oneunitis definedastheamountofenzymerequiredto linearize
1 mg of a pUC 19 derivative in 1 h at 37 C in a reaction volume of 50 ml.
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single site substrates as exempliﬁed in Figures 2 and 5. A
control digest conﬁrmed that wt pUC19 is resistant to cleavage
by variant M91V/E156K (data not shown). The complete
analysis indicates that variant M91V/E156K is able to
cleave seven miscognate sites with nearly the same efﬁciency
as cleavage of the cognate NotI site. In contrast, nearly exclus-
ive nicking was found to occur at 50-GCGTCCGC-30 (data not
shown). It appears that ds cleavage at the other asymmetric
sites may proceed through a nicked intermediate as indicated
bytransientformationofaslowermobilityspeciesinFigures2
and 5. Considering the homodimeric nature of wt NotI, we
expected that variant M91V/ E156K would be able to act
upon a symmetric 8 bp site. However, cleavage of the closely
related 50-GCTGCAGC-30 sequence was not detectable.
The data of Figures 2 and 5 provide evidence for the activity
enhancement resulting from the M91V secondary substitu-
tion. Remarkably, this seemingly minor side chain modi-
ﬁcation results in a 32-fold increase in speciﬁc activity
towards 50-GCTGCCGC-30. In fact, M91V/ E156K performs
ds cleavage at several 8 bp sequences with activities ranging
from 1.6 · 10
5 to 1.0 · 10
4 U per mg protein, which is only 3-
to 50-fold lower than the activity of wt NotI towards its cog-
nate sequence.
A competition assay was conducted to evaluate cleavage of
this alternative site in a reaction where the wt NotI recognition
sequence is also present. Figure 6 shows the results of incub-
ating variant M91V/E156K with equimolar amounts of two
linear substrates derived from pUC-NotI and pUC-GCT. Com-
plete cleavage of both substrates occurs at nearly the same
enzyme level indicating a slight preference for the wt recog-
nition sequence. The practicality of using variant M91V/
E156K in extended DNA digestion reactions was tested by
incubating excess enzyme (E/S ¼ 30) with 1 mg T7 genomic
DNA for times ranging up to 16 h. A virtual digest by
NEBcutter (32) is given in Figure 7A while the actual results
are displayedinFigure7B. (Notethatdscleavage at50-GCGT-
CCGC-30 and was excluded in the virtual digest since this
site is primarily nicked). The cleavage pattern at 1 h is nearly
identical to the cleavage pattern at 16 h. As indicated by the
data in Table 2, cleavage at 50-GCAGCCGC-30 is slow even
with excess enzyme. This leads to slow production of frag-
ments 3 and 5 as listed in the table within Figure 7A. However,
anomalous DNA digestion is not observed after the 16 h
incubation time. These results and the results of digesting
various other substrates in this study provide a high degree
of certainty that the substrate speciﬁcity of M91V/E156K has
been fully characterized.
Finally, we conﬁrmed that the activity of M91V/E156K is
not an exaggerated star activity of the wt enzyme. A thorough
study of wt NotI was conducted using the plasmid substrates
listed in Table 2 so that non-speciﬁc nicking or ds cleavage
would be revealed. Limited ds cleavage was only detected at
ACGGCCGC when the E/S ratio exceeded one and when low
salt conditions were used (NEB buffer 2 with 50 mM NaCl).
When using a recommended buffer (i.e. NEB buffer 3 con-
taining 100 mM NaCl) no star activity was detected with a
molar excess of wt enzyme.
DISCUSSION
REases exhibiting 8 bp substrate speciﬁcity are rarely isolated
from nature (see REBASE). This may be partly due to screen-
ing methods but, most likely, such enzymes are indeed rare
specimens. The objective of this project was to alter the
speciﬁcity of the native REase NotI to obtain an enzyme
with novel speciﬁcity towards one or more alternative 8 bp
sites. The absence of a three dimensional structure of NotI led
us to design an approach based on gene randomization
and in vivo screening and selection. The initial stage of the
project was designed to isolate variants with altered speciﬁ-
city. This was achieved by screening NotI variants within a
DNA-damage indicator strain modiﬁed by a cognate DNA
MTase (1). In this procedure, M.EagI substituted for
M.NotI but it may be considered as cognate since it modiﬁes
50-GCGGCCGC-30 as well as all other 8 bp sequences con-
forming to 50-NCGGCCGN-30. Cells reporting DNA-damage
were expected to contain NotI variants able to cleave one or
more sites differing within the middle 6 bp of the NotI
recognition sequence. Stage 1 yielded variant E156K with
additional cleavage activity at the asymmetric site 50-GCT-
GCCGC-30 (arbitrarily designated as the top strand). Overpro-
duction of variant E156K was enabled by providing a
methylation state to prevent genomic DNA cleavage at sites
Figure 5. Variant M91V/ E156K digestion of plasmid substrate pUC-GCT.
The enzyme/ substrate (E/S) molar ratio is given above each lane. Lane M,
1 kb DNA ladder. All reactions were incubated at 37 C for 60 min in
1 · NEB BamHI buffer. ( ) indicates no enzyme addition.
Figure 6. Competitive cleavage of two linear substrates by variant E156K/
M91V. The 2686 bp substrate was derived from pUC-GCT and the 1778 bp
substrate was derived from pUC-NotI. Equimolar amounts of each substrate
were mixed and incubated with increasing concentrations of enzyme. All
reactions were incubated at 37 C for 60 min in 1· NEB BamHI buffer.
( ) indicates no enzyme addition.
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variant E156K, cleavage at the alternative recognition
sequences was found to be very inefﬁcient. Thus, a second
stage of the project was designed to isolate variants with
enhanced cleavage of the 50-GCTGCCGC-30 target sequence.
Stage 2 was designed as a genetic selection where cell
survival is linked to cleavage of the target sequence residing
within a conditionally toxic vector. The proper level of endo-
nuclease library expression was empirically established so that
up-mutants could be isolated without inﬂicting a lethal level of
genomic DNA-damage. The key consideration of this selec-
tion is the number of target sites within the vector versus the
number within the E.coli genome. In this case, the vector was
designed to encode ten target sequences all ﬂanking the
tox-yidC gene while the E.coli K12 genome possesses over
600 of the target sites (or an average of one per 7 kb). Regard-
less of the unfavorable ratio of sites, the selection procedure
yielded several variants with enhanced speciﬁc activity
towards 50-GCTGCCGC-30. The fact that multiple clones of
the same genotype were selected out of a library of 1 · 10
7 is
evidence that these blue colonies did not appear by chance.
Spontaneous loss of the toxicvector(at afrequencyof0.7%) is
a source of survivors but the additional requirement of blue
colony phenotype nearly eliminated interference by false
positives. In fact, only the two selected parent clones may
be regarded as false positives. Further selection procedures
will employ a vector with multiple copies of the ﬁnal desired
recognition sequence 50-GCTGCAGC0-30. This site occurs
only 104 times within the E.coli genome (every 44 kb on
average). We speculate that variant M91V/E156K may be
further mutated to cleave this symmetric site.
The secondary amino acid substitutions present in the
most active stage 2 variants were M91V, F157C and
V348M. A suppressor substitution at position 157 might be
expected in this situation and can be rationalized in terms of
spatial constraints. Replacing phenylalanine with cysteine
compensates for a larger side chain at position 156 in the
parent E156K. However, the relevance of compensatory
side chain functionality is difﬁcult to discuss without an X-
ray structure. Most likely, E156 is a DNA contacting residue
due to the severe effect of inserting a lysine at this position.
Supporting this idea is an observation that E156 falls in the
middle of a putative Type II active site consensus motif:
TD(X)12EVE (position T151 to E167). Another prediction
based on alignment with EagI indicates that the active site
residues may be FD(X)21EIQ (position F159 to Q184). In any
case, E156 is expected to be in close proximity to the DNA
substrate. In contrast, it is indeed possible that residue 91 and/
or residue 348 be located some distance away from the
protein–DNA interface. As observed in the study of BsoBI,
most suppressor substitutions were not in direct contact with
DNA or even in the vicinity of the original amino acid
substitution (5). Subtle changes (such as M91V or V348M)
are clearly important for acquiring efﬁcient cleavage of a new
DNA sequence. Many structure-guided endeavors have shown
that REase speciﬁcity cannot be distinctly altered by simply
substituting DNA contact residues (33–38).
One may imagine that NotI variant (M91V/E156K) is an
‘intermediate’ on an evolutionary pathway. The parent speci-
ﬁcity 50-GCGGCCGC-30 is still retained; yet several new
sequences yield to cleavage. The results of the competition
assay conﬁrm that the double variant is losing the ability to
recognize the NotI site, which is an eventual goal of this
project. Recognition of 50-GCTGCCGC-30 may be considered
as one step toward recognition of the palindromic sequence
50-GCTGCAGC-30. This desired speciﬁcity is also compatible
with M.BbvI (50-GCWGC-30) host protection so further
laboratory evolution would employ this MTase for REase
over-expression steps. Evolution of REase speciﬁcity in nature
is not well characterized. A recent study argues that MboI is
evolutionarily related to EcoRI, despite the fact of divergent
substrate speciﬁcity (39). This proposition gains more
credence if DNA MTases are brought into the discussion.
The primary determinant of REase speciﬁcity may be, in
fact, the partner MTase. Without adequate host protection,
REase evolution may not be possible. One scenario is
co-evolution of MTase and REase speciﬁcity. But equally
likely (and possible in the case of MboI) is the scenario of
REase evolution to match the speciﬁcity of an acquired or
existing MTase. The laboratory evolution of BstYI (3) was
based on evolving REase function to match an existing MTase
Figure 7. Digestion of T7 genomic DNA by variant M91V/ E156K. (A)A
virtualdigestofT7DNAusingNEBcutter(29).Sincesite50-GCGTCCGC-30 is
nicked by this enzyme it was not included in the virtual digest. M is a size
marker lane. (B) Actual results of digesting T7 DNA in 1· NEB BamHI
buffer for various times at 37 C. A 30-fold molar excess of enzyme was
used in each reaction. (C) A control showing no digestion of T7 DNA by
200 U wt NotI.
Nucleic Acids Research, 2006, Vol. 34, No. 3 803speciﬁcity. Similarly, another step forward can be taken in
the evolution of NotI by carrying out a procedure analogous
to that applied to BstYI. Many recent advances in endonuc-
lease engineering have one feature in common. Genetic
methods were applied to enzymes or variants whose cytotox-
icity is ‘manageable’. The selection system established for
evolving NotI may be applied to other rare-cutting REases
or homing endonucleases. Engineered endonucleases with
speciﬁcity in the 8–18 bp range will bridge a gap left by
the forces of nature.
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